Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1992 Dec;90(6):2434–2438. doi: 10.1172/JCI116134

Estrogen receptors and biologic response in rat parathyroid tissue and C cells.

T Naveh-Many 1, G Almogi 1, N Livni 1, J Silver 1
PMCID: PMC443399  PMID: 1469095

Abstract

The expression of the PTH and calcitonin genes is dramatically decreased by 1,25(OH)2D3 in vivo, and the PTH gene expression is increased by hypocalcemia. We have now studied the effect of estrogens on the expression of these genes in vivo. 17 beta-Estradiol, given to ovariectomized rats, led to a fourfold increase in PTH mRNA and calcitonin mRNA levels. These effects occurred 24 h after single injections of 37-145 nmol estradiol, or after constant infusions of 12 pmol/d for 1 or 2 wk, where there was no effect on serum calcium levels. The estrogen receptor mRNA was demonstrated in the thyroparathyroid tissue by polymerase chain reaction. The estrogen binding was localized to the parathyroid and C cells by immunohistochemistry. Uterus weight was increased by repeated larger doses (73 nmol/d x 7) of estradiol, but not by the small doses (12 pmol/d for 1 or 2 wk) which were effective on the PTH and calcitonin genes, suggesting a sensitive endocrine effect. These results confirm that the parathyroid and C cells are target organs for estrogen, leading to an increased expression of PTH and calcitonin, which by their combined anabolic effect on bone would help prevent osteoporosis.

Full text

PDF
2434

Images in this article

2435Image
on p.2435
2435Image
on p.2435
2435Image
on p.2435
2435Image
on p.2435
2435Image
on p.2435
2436Image
on p.2436
2436Image
on p.2436
2436Image
on p.2436
2436Image
on p.2436
2437Image
on p.2437

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colditz G. A., Stampfer M. J., Willett W. C., Hennekens C. H., Rosner B., Speizer F. E. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA. 1990 Nov 28;264(20):2648–2653. [PubMed] [Google Scholar]
  2. Cote G. J., Rogers D. G., Huang E. S., Gagel R. F. The effect of 1,25-dihydroxyvitamin D3 treatment on calcitonin and calcitonin gene-related peptide mRNA levels in cultured human thyroid C-cells. Biochem Biophys Res Commun. 1987 Nov 30;149(1):239–243. doi: 10.1016/0006-291x(87)91630-5. [DOI] [PubMed] [Google Scholar]
  3. Dick I. M., Prince R. L. Transdermal estrogen replacement does not increase calcitonin secretory reserve in postmenopausal women. Acta Endocrinol (Copenh) 1991 Sep;125(3):241–245. doi: 10.1530/acta.0.1250241. [DOI] [PubMed] [Google Scholar]
  4. Duarte B., Hargis G. K., Kukreja S. C. Effects of estradiol and progesterone on parathyroid hormone secretion from human parathyroid tissue. J Clin Endocrinol Metab. 1988 Mar;66(3):584–587. doi: 10.1210/jcem-66-3-584. [DOI] [PubMed] [Google Scholar]
  5. Eriksen E. F., Colvard D. S., Berg N. J., Graham M. L., Mann K. G., Spelsberg T. C., Riggs B. L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988 Jul 1;241(4861):84–86. doi: 10.1126/science.3388021. [DOI] [PubMed] [Google Scholar]
  6. Ernst M., Heath J. K., Rodan G. A. Estradiol effects on proliferation, messenger ribonucleic acid for collagen and insulin-like growth factor-I, and parathyroid hormone-stimulated adenylate cyclase activity in osteoblastic cells from calvariae and long bones. Endocrinology. 1989 Aug;125(2):825–833. doi: 10.1210/endo-125-2-825. [DOI] [PubMed] [Google Scholar]
  7. Ernst M., Schmid C., Froesch E. R. Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2307–2310. doi: 10.1073/pnas.85.7.2307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fukayama S., Tashjian A. H., Jr Direct modulation by estradiol of the response of human bone cells (SaOS-2) to human parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 1989 Jan;124(1):397–401. doi: 10.1210/endo-124-1-397. [DOI] [PubMed] [Google Scholar]
  9. Gallagher J. C., Riggs B. L., DeLuca H. F. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab. 1980 Dec;51(6):1359–1364. doi: 10.1210/jcem-51-6-1359. [DOI] [PubMed] [Google Scholar]
  10. Goldman L., Tosteson A. N. Uncertainty about postmenopausal estrogen. Time for action, not debate. N Engl J Med. 1991 Sep 12;325(11):800–802. doi: 10.1056/NEJM199109123251108. [DOI] [PubMed] [Google Scholar]
  11. Gray T. K., Flynn T. C., Gray K. M., Nabell L. M. 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6267–6271. doi: 10.1073/pnas.84.17.6267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Greenberg C., Kukreja S. C., Bowser E. N., Hargis G. K., Henderson W. J., Williams G. A. Effects of estradiol and progesterone on calcitonin secretion. Endocrinology. 1986 Jun;118(6):2594–2598. doi: 10.1210/endo-118-6-2594. [DOI] [PubMed] [Google Scholar]
  13. Greenberg C., Kukreja S. C., Bowser E. N., Hargis G. K., Henderson W. J., Williams G. A. Parathyroid hormone secretion: effect of estradiol and progesterone. Metabolism. 1987 Feb;36(2):151–154. doi: 10.1016/0026-0495(87)90009-6. [DOI] [PubMed] [Google Scholar]
  14. Hesch R. D., Busch U., Prokop M., Delling G., Rittinghaus E. F. Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients. Calcif Tissue Int. 1989 Mar;44(3):176–180. doi: 10.1007/BF02556561. [DOI] [PubMed] [Google Scholar]
  15. Hurley D. L., Tiegs R. D., Barta J., Laakso K., Heath H., 3rd Effects of oral contraceptive and estrogen administration on plasma calcitonin in pre- and postmenopausal women. J Bone Miner Res. 1989 Feb;4(1):89–95. doi: 10.1002/jbmr.5650040113. [DOI] [PubMed] [Google Scholar]
  16. Kalu D. N., Liu C. C., Salerno E., Hollis B., Echon R., Ray M. Skeletal response of ovariectomized rats to low and high doses of 17 beta-estradiol. Bone Miner. 1991 Sep;14(3):175–187. doi: 10.1016/0169-6009(91)90021-q. [DOI] [PubMed] [Google Scholar]
  17. Kiel D. P., Felson D. T., Anderson J. J., Wilson P. W., Moskowitz M. A. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med. 1987 Nov 5;317(19):1169–1174. doi: 10.1056/NEJM198711053171901. [DOI] [PubMed] [Google Scholar]
  18. Koike S., Sakai M., Muramatsu M. Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res. 1987 Mar 25;15(6):2499–2513. doi: 10.1093/nar/15.6.2499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Komm B. S., Terpening C. M., Benz D. J., Graeme K. A., Gallegos A., Korc M., Greene G. L., O'Malley B. W., Haussler M. R. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988 Jul 1;241(4861):81–84. doi: 10.1126/science.3164526. [DOI] [PubMed] [Google Scholar]
  20. Lazaretti-Castro M., Grauer A., Mekonnen Y., Raue F., Ziegler R. Effects of 17 beta-estradiol on calcitonin secretion and content in a human medullary thyroid carcinoma cell line. J Bone Miner Res. 1991 Nov;6(11):1191–1195. doi: 10.1002/jbmr.5650061108. [DOI] [PubMed] [Google Scholar]
  21. Liu C. C., Kalu D. N. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res. 1990 Sep;5(9):973–982. doi: 10.1002/jbmr.5650050911. [DOI] [PubMed] [Google Scholar]
  22. Mohan S., Jennings J. C., Linkhart T. A., Baylink D. J. Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Biochim Biophys Acta. 1988 Jul 14;966(1):44–55. doi: 10.1016/0304-4165(88)90127-4. [DOI] [PubMed] [Google Scholar]
  23. Naveh-Many T., Friedlaender M. M., Mayer H., Silver J. Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology. 1989 Jul;125(1):275–280. doi: 10.1210/endo-125-1-275. [DOI] [PubMed] [Google Scholar]
  24. Naveh-Many T., Marx R., Keshet E., Pike J. W., Silver J. Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest. 1990 Dec;86(6):1968–1975. doi: 10.1172/JCI114931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Naveh-Many T., Silver J. Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat. J Clin Invest. 1988 Jan;81(1):270–273. doi: 10.1172/JCI113305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Naveh-Many T., Silver J. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Clin Invest. 1990 Oct;86(4):1313–1319. doi: 10.1172/JCI114840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. O'Keane J. C., Okon E., Moroz K., Burke B., Sheahan K., O'Brien M. J. Anti-estradiol immunoperoxidase labeling of nuclei, not cytoplasm, in paraffin sections, determines estrogen receptor status of breast cancer. Am J Surg Pathol. 1990 Feb;14(2):121–127. doi: 10.1097/00000478-199002000-00003. [DOI] [PubMed] [Google Scholar]
  28. Okazaki T., Igarashi T., Kronenberg H. M. 5'-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J Biol Chem. 1988 Feb 15;263(5):2203–2208. [PubMed] [Google Scholar]
  29. Prince R. L., MacLaughlin D. T., Gaz R. D., Neer R. M. Lack of evidence for estrogen receptors in human and bovine parathyroid tissue. J Clin Endocrinol Metab. 1991 Jun;72(6):1226–1228. doi: 10.1210/jcem-72-6-1226. [DOI] [PubMed] [Google Scholar]
  30. Prince R. L., Schiff I., Neer R. M. Effects of transdermal estrogen replacement on parathyroid hormone secretion. J Clin Endocrinol Metab. 1990 Nov;71(5):1284–1287. doi: 10.1210/jcem-71-5-1284. [DOI] [PubMed] [Google Scholar]
  31. Reeve J., Meunier P. J., Parsons J. A., Bernat M., Bijvoet O. L., Courpron P., Edouard C., Klenerman L., Neer R. M., Renier J. C. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J. 1980 Jun 7;280(6228):1340–1344. doi: 10.1136/bmj.280.6228.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Reginster J. Y., Deroisy R., Albert A., Denis D., Lecart M. P., Collette J., Franchimont P. Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics. J Clin Invest. 1989 Mar;83(3):1073–1077. doi: 10.1172/JCI113950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rodan G. A. Mechanical loading, estrogen deficiency, and the coupling of bone formation to bone resorption. J Bone Miner Res. 1991 Jun;6(6):527–530. doi: 10.1002/jbmr.5650060602. [DOI] [PubMed] [Google Scholar]
  34. Silver J., Naveh-Many T., Mayer H., Schmelzer H. J., Popovtzer M. M. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest. 1986 Nov;78(5):1296–1301. doi: 10.1172/JCI112714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Silver J., Russell J., Sherwood L. M. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4270–4273. doi: 10.1073/pnas.82.12.4270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Silverberg S. J., Shane E., de la Cruz L., Segre G. V., Clemens T. L., Bilezikian J. P. Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis. N Engl J Med. 1989 Feb 2;320(5):277–281. doi: 10.1056/NEJM198902023200503. [DOI] [PubMed] [Google Scholar]
  37. Slovik D. M., Rosenthal D. I., Doppelt S. H., Potts J. T., Jr, Daly M. A., Campbell J. A., Neer R. M. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res. 1986 Aug;1(4):377–381. doi: 10.1002/jbmr.5650010411. [DOI] [PubMed] [Google Scholar]
  38. Turner R. T., Vandersteenhoven J. J., Bell N. H. The effects of ovariectomy and 17 beta-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res. 1987 Apr;2(2):115–122. doi: 10.1002/jbmr.5650020206. [DOI] [PubMed] [Google Scholar]
  39. Wronski T. J., Yen C. F., Scott K. S. Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J Bone Miner Res. 1991 Apr;6(4):387–394. doi: 10.1002/jbmr.5650060410. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES